yes, management are not credible and that's putting it on the mild and nice side...rat tumors not disclosed, every timeline missed, "shareholders will see the value of the pipeline in 2015" not bloody likely, no trials are maturing in 2015. JL is FOS.
you are correct, the mob does naked short and manipulate biotech stocks and the SEC does very little to stop them. Some of this recent activity seems mob-like.
he needs to save us a lot more money and start making real strategic cuts. I checked Linked-in and they are about 75 Arena employees with key word Director in the title. One was a BOD Director Woods, but most of the others appear to be current employees. So, about 1/4 of the work force is a Director and Cindy former IR beauty is a VP of alliances. What alliances, Eisai, from Switzerland? That's going well.
I never thought I would be rooting for Opec, price manipulation, etc. but then I always avoided oil stocks until the first move into the $40's. Come on Book value! Is BBEP for sale?
Who is the Chairman of the BOD for Arena? It seem to me that Jack is Chairman, CEO, President. It seems there are no checks on his authority (maybe that's why the CFO and IR person both quit). This is bad corp governance and may be in violation of the company's own bylaws . The BOD seems to be bought and paid for. IMO of course and just my observation.
Looks like another great day to be an ARNA shareholder!
what's your solution? Are you satisfied with the current price, performance of management, communications and progress of the company? Is Jack still a credible CEO to you? Do you think Arena could find a stronger, more qualified leader? Do you think Arena should continue burning $120MM/yr and diluting shareholders? I think shorts (low stock price) have eliminated every option except major cuts, focus on the pipeline and then a sale. The company has about 18 months of cash at the current burn rate, which is likely to go up, not down with 2 ongoing phase II trials. They can't afford basic research and they can't afford to own a plant unless they fully utilize the plant. They have too many "directors" and other senior level people and need to start cuts ASAP.
most of the development/trial work is done by a 3rd party, they need to massively reduce research, focus on development to value stage then sell the company. We don't need any more failed partnerships, find us a buyer...They can't do another secondary and can't keep burning $120MM/yr any longer.
if you don't try, you will fail. One BOD member is a professor. It's easy to find contact info for prof's.
Angry, concerned shareholders should be all over the BOD to make the necessary changes 1) remove/replace JL 2) cut costs 3) communicate all options are on the table and do an auction
who will join me in applying pressure to the BOD to remove JL? There's no plan, no communication, no leadership and hopefully some value above and beyond the current price. But, they can't continue to burn cash at such a high rate! They need to cut NOW/yesterday.
Arena independent BOD members with profiles on Linked-in include:
Please contact them today and let them know what you think of Jack Leif's leadership and communication skills and results! We need a plan, a sale, some communications, new leadership, major cost reductions... NOW!!!
where is this $11BB Jefferies article? Thomas Wei is, or was the Jeff biotech stock analyst following ARNA and I doubt he's very positive after placing his bet on Bel-phen and ARNA/E's inability or lack of focus on moving this combo forward.
More baseless hype. JL fiddles while ARNA shareholders burn.
It must be expensive for shorts to borrow shares and continue selling every morning and then covering at the end of the day. Maybe not, it's working. I hate to blame the price on shorts, it's more about JL's failure, but they are doing technical and psych damage on the company and stock. It's a war, seems to be personal for them and they are winning. JL is not equipped, not a general.
it's positive the question is, will this result in higher sales and if so, when and how much? Eisai is not doing much to market the drug, ARNA does nothing to market the company. I think we are in for 12+ months of short and long babble and depressed prices until new clinical trial data are available. IMO of course, many things + and - could happen sooner.
amen brother, you are on a roll. Jack and Jill or Jack and Jail? I can no longer use the bean counter since he jumped ship. For how long can the BOD protect his incompetent rear? I have been urging him and Craig to sell, cut costs, or find a competent CEO before it's too late...